慢加急性肝衰竭的免疫治疗
炎症反应和免疫功能紊乱在慢加急性肝衰竭的病程进展中发挥关键作用,导致全身炎症反应综合征,过度的炎症及免疫反应,导致感染易感性增加,最终出现多脏器功能衰竭(MODS)。消除肝损伤并纠正免疫紊乱可预防败血症和(或)MODS,改善患者的生存。迄今为止,ACLF的免疫治疗在各大治疗指南中尚未被推荐。然而,作为ACLF重要病理生理改变,并且与发病率、病死率密切相关的关键事件——肝脏局部和全身炎症反应持续激活及免疫细胞功能障碍,又促使我们不得不考虑免疫调节治疗,以阻断和逆转疾病的进展。因此,简述了目前应用于ACLF治疗的具有潜在免疫调节作用的药物,包括传统药物白蛋白、糖皮质激素等使用,粒细胞集落刺激因子、...
Saved in:
Published in | 临床肝胆病杂志 Vol. 33; no. 9; pp. 1677 - 1682 |
---|---|
Main Author | |
Format | Journal Article |
Language | Chinese |
Published |
第四军医大学西京消化病医院,西安,710032
2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1001-5256 |
DOI | 10.3969/j.issn.1001-5256.2017.09.010 |
Cover
Abstract | 炎症反应和免疫功能紊乱在慢加急性肝衰竭的病程进展中发挥关键作用,导致全身炎症反应综合征,过度的炎症及免疫反应,导致感染易感性增加,最终出现多脏器功能衰竭(MODS)。消除肝损伤并纠正免疫紊乱可预防败血症和(或)MODS,改善患者的生存。迄今为止,ACLF的免疫治疗在各大治疗指南中尚未被推荐。然而,作为ACLF重要病理生理改变,并且与发病率、病死率密切相关的关键事件——肝脏局部和全身炎症反应持续激活及免疫细胞功能障碍,又促使我们不得不考虑免疫调节治疗,以阻断和逆转疾病的进展。因此,简述了目前应用于ACLF治疗的具有潜在免疫调节作用的药物,包括传统药物白蛋白、糖皮质激素等使用,粒细胞集落刺激因子、人工肝支持系统及间充质干细胞移植等的应用,并讨论了一些有希望的未来免疫治疗靶点。 |
---|---|
AbstractList | R575.3; 炎症反应和免疫功能紊乱在慢加急性肝衰竭的病程进展中发挥关键作用,导致全身炎症反应综合征,过度的炎症及免疫反应,导致感染易感性增加,最终出现多脏器功能衰竭(MODS).消除肝损伤并纠正免疫紊乱可预防败血症和(或)MODS,改善患者的生存.迄今为止,ACLF的免疫治疗在各大治疗指南中尚未被推荐.然而,作为ACLF重要病理生理改变,并且与发病率、病死率密切相关的关键事件——肝脏局部和全身炎症反应持续激活及免疫细胞功能障碍,又促使我们不得不考虑免疫调节治疗,以阻断和逆转疾病的进展.因此,简述了目前应用于ACLF治疗的具有潜在免疫调节作用的药物,包括传统药物白蛋白、糖皮质激素等使用,粒细胞集落刺激因子、人工肝支持系统及间充质干细胞移植等的应用,并讨论了一些有希望的未来免疫治疗靶点. 炎症反应和免疫功能紊乱在慢加急性肝衰竭的病程进展中发挥关键作用,导致全身炎症反应综合征,过度的炎症及免疫反应,导致感染易感性增加,最终出现多脏器功能衰竭(MODS)。消除肝损伤并纠正免疫紊乱可预防败血症和(或)MODS,改善患者的生存。迄今为止,ACLF的免疫治疗在各大治疗指南中尚未被推荐。然而,作为ACLF重要病理生理改变,并且与发病率、病死率密切相关的关键事件——肝脏局部和全身炎症反应持续激活及免疫细胞功能障碍,又促使我们不得不考虑免疫调节治疗,以阻断和逆转疾病的进展。因此,简述了目前应用于ACLF治疗的具有潜在免疫调节作用的药物,包括传统药物白蛋白、糖皮质激素等使用,粒细胞集落刺激因子、人工肝支持系统及间充质干细胞移植等的应用,并讨论了一些有希望的未来免疫治疗靶点。 |
Abstract_FL | Inflammatory response and immune dysfunction play important roles in the progression of acute-on-chronic liver failure (ACLF) and may lead to systemic inflammatory response syndrome.Excessive inflammatory and immune response may result in increased susceptibility to infection and finally lead to multiple organ dysfunction syndrome (MODS).Elimination of liver injury and correction of immune dysfunction can prevent sepsis and/or MODS and improve patients' survival.Up to now,immunotherapy for ACLF has not been recommended in related guidelines.However,as an important pathophysiological change of ACLF and a key event closely associated with incidence rate and mortality rate,persistent activation of hepatic and systemic inflammatory response and immune cel1 dysfunction urges us to consider immunoregulatory treatment,in order to block and reverse disease progression.This article introduces potential immunoregulatory drugs for the treatment of ACLF,including albumin,glucocorticoids,granulocyte colony-stimulating factor,artificial liver support system,and mesenchymal stem cell transplantation,and discusses some promising targets for immunotherapy. |
Author | 韩英 崔丽娜 郭冠亚 |
AuthorAffiliation | 第四军医大学西京消化病医院,西安710032 |
AuthorAffiliation_xml | – name: 第四军医大学西京消化病医院,西安,710032 |
Author_FL | CUI Lina GUO Guanya HAN Ying |
Author_FL_xml | – sequence: 1 fullname: HAN Ying – sequence: 2 fullname: CUI Lina – sequence: 3 fullname: GUO Guanya |
Author_xml | – sequence: 1 fullname: 韩英 崔丽娜 郭冠亚 |
BookMark | eNo9j81Kw0AUhWdRwVr7EtKFm8Q7M5kZZynFPyi40H24mUxqSp1ogohdFbEbwW0FQVBBXBRB3Po8TfoYRiquDhw-zuFbIw2XOUtIh4LPtdRbAz8tCudTAOoJJqTPgCoftA8UGqT536-SdlGkEQjKpQ6EbJJOOXmd3z2X47dy_L64eVq8fFazj-rxdj65r6az8uu7mj6sk5UEh4Vt_2WLHO_tnnQPvN7R_mF3p-cZCeCZADRLcBsZ57EUKJURVAttKdeRRg4qYFYkmloLGKNChoZqCNAgJirhLbK5XL1Cl6Drh4PsMnf1Xzg0_TgajX6lQNdKNbqxRM1p5voXaQ2f5-kZ5tehVJxJJQPgP2J9XUY |
ClassificationCodes | R575.3 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.3969/j.issn.1001-5256.2017.09.010 |
DatabaseName | 中文期刊服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Immunotherapy for acute-on-chronic liver failure |
DocumentTitle_FL | Immunotherapy for acute-on-chronic liver failure |
EndPage | 1682 |
ExternalDocumentID | lcgdbzz201709010 673267640 |
GroupedDBID | -05 2B. 2C~ 2RA 5XA 5XF 92F 92I 92L ABDBF ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 EAD EAP EOJEC ESX GROUPED_DOAJ IPNFZ OBODZ OK1 RIG RNS TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI ACUHS PSX |
ID | FETCH-LOGICAL-c600-c4092fa8a233d65a67c51959e139b9a30742e5f91ee0ada7a2ac1904acaaf7f3 |
ISSN | 1001-5256 |
IngestDate | Thu May 29 03:59:50 EDT 2025 Wed Feb 14 09:57:01 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | 肝功能衰竭 多器官功能衰竭 免疫疗法 治疗 multiple organ failure liver failure therapy immunotherapy |
Language | Chinese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c600-c4092fa8a233d65a67c51959e139b9a30742e5f91ee0ada7a2ac1904acaaf7f3 |
Notes | HAN Ying, CUI Lina, GUO Guanya. ( Xijing Hospital of Digestive Disease, Fourth Military Medical University, Xi'an 710032, China) liver failure; multiple organ failure; immunotherapy; therapy Inflammatory response and immune dysfunction play important roles in the progression of acute-on-chronic liver failure( ACLF) and may lead to systemic inflammatory response syndrome. Excessive inflammatory and immune response may result in increased susceptibility to infection and finally lead to multiple organ dysfunction syndrome( MODS). Elimination of liver injury and correction of immune dysfunction can prevent sepsis and/or MODS and improve patients'survival. Up to now,immunotherapy for ACLF has not been recommended in related guidelines. However,as an important pathophysiological change of ACLF and a key event closely associated with incidence rate and mortality rate,persistent activation of hepatic and systemic inflammatory response and immune cell dysfunction urges us to consider immunoregulatory treatment,in order |
PageCount | 6 |
ParticipantIDs | wanfang_journals_lcgdbzz201709010 chongqing_primary_673267640 |
PublicationCentury | 2000 |
PublicationDate | 2017 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – year: 2017 text: 2017 |
PublicationDecade | 2010 |
PublicationTitle | 临床肝胆病杂志 |
PublicationTitleAlternate | Chinese Journal of Clinical Hepatology |
PublicationTitle_FL | Journal of Clinical Hepatology |
PublicationYear | 2017 |
Publisher | 第四军医大学西京消化病医院,西安,710032 |
Publisher_xml | – name: 第四军医大学西京消化病医院,西安,710032 |
SSID | ssib051369456 ssj0041983 ssib001103858 ssib053243598 ssib002264326 ssib038074677 |
Score | 2.0629666 |
Snippet | ... R575.3;... |
SourceID | wanfang chongqing |
SourceType | Aggregation Database Publisher |
StartPage | 1677 |
SubjectTerms | 免疫疗法 多器官功能衰竭 治疗 肝功能衰竭 |
Title | 慢加急性肝衰竭的免疫治疗 |
URI | http://lib.cqvip.com/qk/90100X/201709/673267640.html https://d.wanfangdata.com.cn/periodical/lcgdbzz201709010 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NaxQxFA_rFooX8RNrVSrsO5Wpk5lMJjkm3V2KUC9W6G3JZGa2B9n6sb3sqUh7EbxWEAQVxEMRxKt_T3f7Z5hkMtupSFFhGbJv895L9s2E34T3fkGoQ7m2wFYFOMVZQHSYB1mZ50FYkEJjUurSHeez-ZhuPCWPtpPtVuugkbW0N87W9OSPdSX_E1UjM3G1VbL_ENm5USMwbRNfczURNte_ijH0KLAERAS9BJgAETpJCCKpGyn0GLAIeNc2BAZp-qQgJIiubXABjDh186kk1P5q1GUEUnpJld1ao1joEZAMpFOUwrpuemExMOoUU2vWmDJy5gYp-7UpE2ToceB9ENwpSZB41fUhwEntomslggFfX7XdjWnhRMaBnS2x7rlo7l1URZp-obWpXElUkYrXK3FFieHvON5YVjH1Z70U_mt1YNHvy3_MKXfLv3WxNndhE_hSx2brM2jPE2zT1EDYlJLwElqI0hQnbbQgZFf2z2AlDs9x_tji4wbstZz9pEELmOCYcnLGUZQY0GqJEmuEQDBnVeGHH-Ai6vjRP7xo7Jb-Y2d3NHxhQI2rMRuVajRswKGtq-iKf49ZEdVNeQ21JjvX0eKmz9S4gTrTw88nbz5O979M97-evv5w-un77Pjb7P3ByeHb2dHx9MfP2dG7m-hJv7e1vhH4EzkCbYBxoEnIo1IxFcVxThNFU-3IiQrzGpFxFdt9liIpOS6KUOUqVZHSBnASpZUq0zK-hdqj3VFxG60Y1JoVPIsJZ5ioXGeqiHJKi1IzwjKKl9DyfKqD5xXvymAeqCX0wE9-4J_GV4Nnephnk4n9u0KbcnTnQgvL6LLtWe2l3UXt8cu94p5Bl-Psvg_-L7R4V1o |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%85%A2%E5%8A%A0%E6%80%A5%E6%80%A7%E8%82%9D%E8%A1%B0%E7%AB%AD%E7%9A%84%E5%85%8D%E7%96%AB%E6%B2%BB%E7%96%97&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E9%9F%A9%E8%8B%B1+%E5%B4%94%E4%B8%BD%E5%A8%9C+%E9%83%AD%E5%86%A0%E4%BA%9A&rft.date=2017&rft.issn=1001-5256&rft.volume=33&rft.issue=9&rft.spage=1677&rft.epage=1682&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2017.09.010&rft.externalDocID=673267640 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg |